Literature DB >> 7878935

Sandimmun neoral pharmacokinetics: impact of the new oral formulation.

D W Holt1, E A Mueller, J M Kovarik, J B van Bree, F Richard, K Kutz.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7878935

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

Review 1.  Therapeutic drug monitoring of immunosuppressant drugs.

Authors:  A Johnston; D W Holt
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

Review 2.  Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides.

Authors:  Lei Diao; Bernd Meibohm
Journal:  Clin Pharmacokinet       Date:  2013-10       Impact factor: 6.447

3.  [Oral bioavailability of oncological preparations: the intake conditions are often decisive].

Authors:  W Weitschies
Journal:  Urologe A       Date:  2014-12       Impact factor: 0.639

Review 4.  Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.

Authors:  A J Coukell; G L Plosker
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

5.  Cyclosporin therapeutic drug monitoring--an established service revisited.

Authors:  Raymond G Morris
Journal:  Clin Biochem Rev       Date:  2003-05

Review 6.  Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients.

Authors:  Atholl Johnston; Philip Belitsky; Ulrich Frei; John Horvath; Peter Hoyer; J Harold Helderman; Michael Oellerich; Stephen Pollard; Hany Riad; Paolo Rigotti; Paul Keown; Björn Nashan
Journal:  Eur J Clin Pharmacol       Date:  2004-06-17       Impact factor: 2.953

7.  A review on therapeutic drug monitoring of immunosuppressant drugs.

Authors:  Niloufar Mohammadpour; Sepideh Elyasi; Naser Vahdati; Amir Hooshang Mohammadpour; Jamal Shamsara
Journal:  Iran J Basic Med Sci       Date:  2011-11       Impact factor: 2.699
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.